Plain-English translation of NCT07280065 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
The REVEAL Study is testing a new smartphone app called the Senseye Diagnostic Tool that uses your phone's camera and simple tasks to help diagnose post-traumatic stress disorder (PTSD). The app analyzes video recordings to look for physical signs that might suggest PTSD, and researchers want to see how accurate it is compared to traditional in-person interviews with mental health professionals.
PTSD diagnosis currently requires time-consuming interviews with trained clinicians, which can be hard to access for many people. This study is exploring whether a smartphone app could offer a faster, more convenient way to help diagnose PTSD and measure how severe it is.
You likely qualify if…
You likely don't qualify if…
You'll start with a brief screening visit by video to confirm you're eligible. Then you'll have 2–3 study visits: first, a virtual appointment where a trained clinician will conduct standard mental health interviews; second, you'll use the smartphone app at either a study site (if nearby) or at home; and possibly a third visit for additional assessments. The whole process compares how well the app works against the traditional clinical interviews, which are considered the gold standard for PTSD diagnosis.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
United States